WuXi AppTec logo

WuXi AppTec(OTC) WUXIF

Market Cap$78.67BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)+130%
5 Year+27%
1 Year+92%
1 Month+2%
$26.49
-1.00%
-0.27Today
WuXi AppTec last closing stock price
MetricPriceDate
Last closeUSD 26.492026-10-05
WuXi AppTec stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-0.12%USD 26.522026-09-28
1 month+2.46%USD 25.852026-09-04
3 month+25.76%USD 21.062026-07-07
Year to date+97.84%USD 13.392025-12-05
1 year+92.18%USD 13.782025-10-03
3 year+166.15%USD 9.952023-09-22
5 year+27.07%USD 20.842021-10-04
Since inception+130.38%USD 11.502020-03-17

WuXi AppTec Financials at a Glance

Market Cap

$78.67BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥53.47B

Net Income (TTM)

CN¥21.62B

EPS (TTM)

$1.06

P/E Ratio

24.51

Dividend

$0.23

Beta (Volatility)

0.14 (Low)

Price

$26.49

Volume

151

Open

$26.49

Previous Close

$26.49

Daily Range

$26.49 - $26.49

52-Week Range

$13.60 - $27.77

Estimated Earnings Date

Oct 27, 2026

WUXIF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About WuXi AppTec

WuXi AppTec Co., Ltd. is a leading global provider of research, development, and manufacturing services for the pharmaceutical and biotechnology industries. The company specializes in facilitating the discovery and production of small molecule pharmaceuticals and innovative cell and gene therapies.

Products and Services
  • Comprehensive contract research, development, and manufacturing services
  • Biology services supporting drug discovery and clinical progression
  • Integrated solutions for cell and gene therapy market entry
Growth Outlook
  • Revenue of CNY 16.39 billion in Q2 2026, a significant increase from Q1 2026
  • Net income of CNY 6.38 billion in Q2 2026, reflecting strong operational efficiency
  • Consistent growth in cash flow, with free cash flow of CNY 4.33 billion in Q2 2026
Financial Highlights
  • Trailing twelve months (TTM) revenue of CNY 49.67 billion, showcasing robust demand
  • Net profit margin of 40.47% TTM, indicating strong profitability
  • Dividend yield of 1.29% TTM, providing a return to shareholders
WuXi AppTec Co., Ltd. operates across multiple regions, including China, the United States, and Europe, positioning itself as a key player in the healthcare sector. The company's diverse service offerings and strong financial performance highlight its potential for continued growth. Recent quarterly results demonstrate a solid upward trajectory in revenue and net income, underscoring the effectiveness of its business model. With a focus on innovation and comprehensive support for drug development, WuXi AppTec is well-positioned to capitalize on the expanding pharmaceutical and biotechnology markets.
AI Generated • Sep 25, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

35,584

CEO

Min Zhang Chen, PhD; Ge Li, PhD; Qing Yang

Website

www.wuxiapptec.com.cn

Headquarters

Shanghai, SH 200131, CN

WUXIF Financials

Key Financial Metrics (TTM)

Gross Margin

51.96%

Operating Margin

42.43%

Net Income Margin

40.47%

Return on Equity

27.24%

Return on Capital

19.33%

Return on Assets

18.58%

Earnings Yield

4.08%

Dividend Yield

0.87%

Payout Ratio

31.55%

Stock Overview

Market Cap

$78.67BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.97B

Volume

151

Avg. Volume

1.71K

Financials (TTM)

Gross Profit

CN¥27.74B

Operating Income

CN¥22.96B

EBITDA

CN¥27.35B

Operating Cash Flow

CN¥19.61B

Capital Expenditure

-CN¥6.39B

Free Cash Flow

CN¥13.22B

Cash & ST Invst.

CN¥46.64B

Total Debt

CN¥15.11B

WuXi AppTec Performance Analysis

WuXi AppTec annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 5,844,438,63764.6%
20232023-12-31CNY 5,459,116,990-6.6%
20242024-12-31CNY 4,969,800,146-9.0%
20252025-12-31CNY 6,040,361,37221.5%
WuXi AppTec sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-308.0%
Q42025-12-314.7%
Q12026-03-31-1.3%
Q22026-06-3031.8%
WuXi AppTec annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.4255.7%
20232023-12-31CNY 0.5122.2%
20242024-12-31CNY 0.45-12.4%
20252025-12-31CNY 0.92104.7%
WuXi AppTec sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-28.8%
Q42025-12-31101.7%
Q12026-03-31-35.2%
Q22026-06-3037.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥16.39B

+47.1%

Gross Profit

CN¥9.15B

+77.1%

Gross Margin

55.79%

N/A

Market Cap

$78.67BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.33M

N/A

Employees

33,834

N/A

Net Income

CN¥6.38B

+30.5%

EBITDA

CN¥7.75B

+35.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥46.64B

+90.9%

Total Debt

CN¥15.11B

+107.2%

Accounts Receivable

CN¥13.00B

+55.3%

Inventory

CN¥9.78B

+36.7%

Long Term Debt

CN¥2.19B

+46.3%

Short Term Debt

CN¥12.92B

+122.9%

Return on Assets

18.58%

N/A

Return on Invested Capital

25.86%

N/A

Free Cash Flow

CN¥4.34B

+51.2%

Operating Cash Flow

CN¥6.10B

+44.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WUXAYWuXi AppTec Co., Ltd.
$27.67+1.84%
CHGCYChugai Pharmaceutical Co., Ltd.
$19.28-0.17%
HOCPFHOYA Corporation
$155.97+6.30%
DSKYFDaiichi Sankyo Company, Limited
$17.69+0.34%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$171.92+0.48%
INTCIntel
$112.50-3.18%
NVDANvidia
$239.24+0.14%
NUNu Holdings
$15.66+3.16%

Questions About WUXIF

What is the current price of WuXi AppTec?

WuXi AppTec is trading at $26.49 per share.

What is the 52-week range for WuXi AppTec?

Over the past 52 weeks, WuXi AppTec has traded between $13.60 and $27.77.

How much debt does WuXi AppTec have?

As of the most recent reporting period, WuXi AppTec reported total debt of CN¥2.23B.

How much cash does WuXi AppTec have on hand?

WuXi AppTec reported CN¥3.98B in cash and cash equivalents in its most recent financial results.

What is WuXi AppTec’s dividend yield?

WuXi AppTec currently has a dividend yield of 0.87%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services